Abstract

PurposeTo determine which head and neck adaptive radiotherapy (ART) correction objectives are feasible and to derive efficient ART patient selection guidelines.MethodsWe considered various head and neck ART objectives including independent consideration of dose-sparing of the brainstem/spinal cord, parotid glands, and pharyngeal constrictor, as well as prediction of patient weight loss. Two-hundred head and neck cancer patients were used for model development and an additional 50 for model validation. Patient chart data, pre-treatment images, treatment plans, on-unit patient measurements, and combinations thereof were assessed as potential predictors of each objective. A stepwise approach identified combinations of predictors maximizing the Youden index of random forest (RF) models. A heuristic translated RF results into simple patient selection guidelines which were further refined to balance predictive capability and practical resource costs. Generalizability of the RF models and simplified guidelines to new data was tested using the validation set.ResultsTop performing RF models used various categories of predictors, however, final simplified patient selection guidelines only required pre-treatment information for ART predictions, indicating the potential for significant ART process streamlining. The simplified guidelines for each objective predicted which patients would experience increases in dose to: brainstem/spinal cord with sensitivity = 1.0, specificity = 0.66; parotid glands with sensitivity = 0.82, specificity = 0.70; and pharyngeal constrictor with sensitivity = 0.84, specificity = 0.68. Weight loss could be predicted with sensitivity = 0.60 and specificity = 0.55. Furthermore, depending on the ART objective, 28%-58% of patients required replan assessment, less than for previous studies, indicating a step towards more effective patient selection.ConclusionsThe above ART objectives appear to be practically achievable, with patients selected for ART according to simple clinical patient selection guidelines. Explicit ART guidelines are rare in the literature, and our guidelines may aid in balancing the potential clinical gains of ART with high associated resource costs, formalizing ART trials, and ensuring the reproducibility of clinical successes.

Highlights

  • The spatial accuracy of IMRT and VMAT for head and neck radiotherapy can degrade over the course of treatment as tumor volumes and patient anatomy change

  • We independently considered nine Adaptive radiation therapy (ART) objectives of interest, where initial random forest (RF) models were developed to predict which patients would experience: 1. Increases in brainstem/spinal cord Dmax - potentially increasing the risk of brainstem necrosis or myelopathy; 2

  • For RF model development, we identified the quartile of patients with the most unfavorable relative changes in objective values (ALARA + poorest quartile formatting)

Read more

Summary

Introduction

The spatial accuracy of IMRT and VMAT for head and neck radiotherapy can degrade over the course of treatment as tumor volumes and patient anatomy change. Previous studies in the literature indicate median decreases in gross tumor volume of 70% [1], and average weight loss of 8% [2] over the course of radical (chemo)radiotherapy. These anatomical changes may cause doses to organs-at-risk (OAR), such as the parotid glands, to increase in by >10 Gy [3], and target coverage to degrade by >5% [4] in select patients. Existing ART models for patient selection show promise but still suffer from limited performance [10, 11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call